JOSEPH ALUIA: Open Payments
NPI 1043970940 · ROSEVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 6 payments from 4 companies in 2025. Trend: 2023 $315 · 2024 $238 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $288 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $123 |
Products named: REXULTI, CAPLYTA.
Industry payments across MI — which companies pay providers there.
